N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C
Modify Date: 2024-01-10 00:09:31
![N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C Structure](https://www.chemsrc.com/caspic/264/202114-53-2.png)
N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C structure
|
Common Name | N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13C | ||
|---|---|---|---|---|
| CAS Number | 202114-53-2 | Molecular Weight | 354.40 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 559.8±33.0 °C at 760 mmHg | |
| Molecular Formula | C2013CH23NO4 | Melting Point | 152-156ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | 292.4±25.4 °C | |
Use of N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Leucine-1-13CFmoc-leucine-13C is a 13C-labeled Boc-Glycine[1]. |
| Name | (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Fmoc-leucine-13C is a 13C-labeled Boc-Glycine[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[75]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 559.8±33.0 °C at 760 mmHg |
| Melting Point | 152-156ºC(lit.) |
| Molecular Formula | C2013CH23NO4 |
| Molecular Weight | 354.40 |
| Flash Point | 292.4±25.4 °C |
| Exact Mass | 353.162720 |
| PSA | 75.63000 |
| LogP | 4.95 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.583 |
| RIDADR | NONH for all modes of transport |
|---|---|
| WGK Germany | 3 |
| L-Leucine-1-13C,N-Fmoc |
| N-(9-Fluorenylmethoxycarbonyl)-L-leucine-1-13C,L-Leucine-1-13C,N-Fmoc |
| MFCD00190328 |
| Fmoc-D-Leu-OH |
| Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]- |
| Fmoc-Leu-OH-1-13C |
| N-[(9H-Fluoren-9-ylmethoxy)carbonyl]leucine |